Trials / Completed
CompletedNCT02597023
The Efficacy of Oral Mitoquinone (MitoQ) Supplementation for Improving Physiological in Middle-aged and Older Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 55 (actual)
- Sponsor
- University of Colorado, Boulder · Academic / Other
- Sex
- All
- Age
- 60 Years – 79 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy of supplementation with the mitochondria-targeted antioxidant, mitoquinone (MitoQ), for improving physiological function (vascular, motor, and cognitive) in middle-aged and older adults.
Detailed description
Overall, the proposed research project has the long-term potential to influence clinical practice by establishing novel therapies for treating multiple domains of age-associated physiological dysfunction and thereby reducing the risk of clinical disease and disability.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MitoQ | Mitoquinone pill, 20 mg/day |
| DRUG | Placebo | Placebo pill with inert excipient, 1 time/day |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2015-11-04
- Last updated
- 2018-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02597023. Inclusion in this directory is not an endorsement.